For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250227:nRSa7706Ya&default-theme=true
RNS Number : 7706Y Indivior PLC 27 February 2025
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM
The Company announces that it received notification on February 27, 2025 that
Dr. David Wheadon, Chair of the Company, acquired a total of 10,000 Ordinary
Shares of US$0.50 each in the Company ('Shares') at an average price of
$8.4281 per share on February 27, 2025.
Following this transaction, Dr. Wheadon has an interest in 10,000 shares in
the Company.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dr. David Wheadon
2 Reason for the notification
a) Position/status Chair
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Indivior PLC
b) LEI 213800V3NCQTY7IED471
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of US$0.50
Identification code
GB00BN4HT335
b) Nature of the transaction Purchase of Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
$8.4281 10,000
d) Aggregated information
N/A
- Aggregated volume
- Price
e) Date of the transaction February 27, 2025
f) Place of the transaction Nasdaq Global Select Market
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
February 27, 2025
f)
Place of the transaction
Nasdaq Global Select Market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHPPURPPUPAGQM